Latest filing published 09 Jan 2025 for 우리바이오.
한국증권금융: trading record in brief
한국증권금융 appears in our data through filings on 우리바이오 shares, published by DART (FSS). Over a trading history stretching from 27 May 2021 to 2 October 2024, the count stands at 8 filings.
In open-market terms, that means 7 purchases on one side and 1 sale on the other. The amount is not disclosed for 8 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2025 to date brings no purchases and 1 sale.
Across 7 purchases, this insider has always bought alone, with no colleague buying within 30 days.
On 9 January 2025 came the latest disclosure, an open-market sale in 우리바이오. The last insider purchase was made public on 8 October 2024, 761 days ago. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Companies and markets linked to 한국증권금융
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 320,380 sharesKRXDART:20241008000160Canonical exit: 6 Jan 2025 (T+90)
- 320,380 sharesKRXDART:20230427000656Canonical exit: 26 Jul 2023 (T+90)
- 320,380 sharesKRXDART:20230406002280Canonical exit: 5 Jul 2023 (T+90)
- 320,380 sharesKRXDART:20211222000334Canonical exit: 22 Mar 2022 (T+90)
- 320,380 sharesKRXDART:20211207000012Canonical exit: 7 Mar 2022 (T+90)
- 320,380 sharesKRXDART:20210928000333Canonical exit: 27 Dec 2021 (T+90)
- 320,380 sharesKRXDART:20210527000490Canonical exit: 25 Aug 2021 (T+90)
8 of 8 declarations